Download Pain Cases

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Pain Cases
GPVTS Nov 08
Case 1 : Hospice patient •
•
•
•
•
•
RM
67/f
2004: Ovarian cancer
oophrectomy +salpingectomy
chemotherapy
2008: Pathological fracture to L5 treated
with Radiotherapy
Case 1 cont.
• Admitted to hospice 1 week later for
symptom control.
• main symptoms:
Pain – lower back, dull ache and intermittent
sharp pain.
Drowsiness – past 24hrs
• medications: MST 60mg bd, pregabalin
150mg bd, paracetamol 1g qid
Case 1
• O/E T=37.4, pulse= 88,
• CVS/RESP/NEURO: NAD
• Q1: what are the possible causes of RM’s
drowsiness
• Q2: what are the possible options to
manage pain?.
CASE 2: House call
•
•
•
•
•
DM
77/M
2008: Gastric Cancer
Not for chemotherapy/Radiotherapy
Poor prognosis
Case 2: cont
•
•
•
•
•
Main symptoms :
pain : Epigastric – severe dull ache
Vomiting : increasing over past few days.
Dysphagia : new onset
Medications: omeprazole 40mg od, MST
120mg bd and PRN oramorph.
metoclopramide 10mg tds
Case 2 cont
• O/E – unwell, grey, restlessness,
• abdo: pain on light palpation in
epigastrium.
• Q1: what analgesics / medications should
be started?
• Q2:what other considerations are there in
managing this patient?
Case 3: telephone call:
•
•
•
•
•
•
PF
80/f
2007: Rectal Cancer
Anterior resection + tumour debulking
chemotherapy + radiotherapy.
2008: Referred to palliative care.
Case 3 cont
• Meds: alfentanil 120mg and 12.5mg
levomepromazine by csci
• Q1. What prn medication should PF be on
and at what dose?
Case 4: Busy surgery
• TM
• 66/f
• Long history of osteoarthritis known:
previous gastric ulcer and renal
impairment
• awaiting knee replacement
• had previous joint injections for pain
Case 4 : cont
• main symptom: severe left knee pain.
• medications: co-codamol 30/500 qid, tramadol
100mg qid
• Q1 what medication could be started?
• Q2. what side effects should you warn the
patient about?